1832 Asset Management’s Medifast MED Stock Holding History

1832 Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-500	Closed	-$21K	–	736
2016 Q4	$21K	Hold	500	–	–	﹤0.01%	603
2016 Q3	$19K	Buy	+500	New	+$17.9K	﹤0.01%	574

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

1832 Asset Management's MED Position: Q1 2017 in Review

1832 Asset Management sold out of Medifast (MED) in Q1 2017, closing a stake of 500 shares — an estimated $21K sold.

1832 Asset Management first reported a position in MED in Q3 2016 and held it in 2 quarters. The position peaked at $21K in Q4 2016. 167 funds tracked by Wall St. Rank hold MED as of Q1 2017.

1832 Asset Management reported no remaining Medifast position as of Q1 2017 after selling out during the quarter.
1832 Asset Management sold 500 Medifast shares in Q1 2017, an estimated $21K.
1832 Asset Management first reported a position in Medifast in Q3 2016 and held it in 2 quarters.
1832 Asset Management's Medifast position peaked at $21K in Q4 2016.
167 funds tracked by Wall St. Rank held Medifast as of Q1 2017.

Based on 1832 Asset Management's 13F filing for Q1 2017, filed 15 May 2017.